Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


Daily Top 10 COVID-19 papers

DEU | ENG | ESP | FRA | ITA | POR | TUR | VNM


  Liver Diseases

  Free Subscription


Articles published in Oncogene

Retrieve available abstracts of 107 articles:
HTML format



Single Articles


    May 2020
  1. TSAI CN, Yu SC, Lee CW, Pang JS, et al
    SOX4 activates CXCL12 in hepatocellular carcinoma cells to modulate endothelial cell migration and angiogenesis in vivo.
    Oncogene. 2020 May 13. pii: 10.1038/s41388-020-1319.
    PubMed     Abstract available


  2. HUANG WJ, Tian XP, Bi SX, Zhang SR, et al
    The beta-catenin/TCF-4-LINC01278-miR-1258-Smad2/3 axis promotes hepatocellular carcinoma metastasis.
    Oncogene. 2020 May 5. pii: 10.1038/s41388-020-1307.
    PubMed     Abstract available


    March 2020
  3. LI W, Dai Y, Shi B, Yue F, et al
    LRPPRC sustains Yap-P27-mediated cell ploidy and P62-HDAC6-mediated autophagy maturation and suppresses genome instability and hepatocellular carcinomas.
    Oncogene. 2020 Mar 16. pii: 10.1038/s41388-020-1257.
    PubMed     Abstract available


  4. HUANG P, Xu Q, Yan Y, Lu Y, et al
    HBx/ERalpha complex-mediated LINC01352 downregulation promotes HBV-related hepatocellular carcinoma via the miR-135b-APC axis.
    Oncogene. 2020 Mar 10. pii: 10.1038/s41388-020-1254.
    PubMed     Abstract available


  5. PINATO DJ, Guerra N, Fessas P, Murphy R, et al
    Immune-based therapies for hepatocellular carcinoma.
    Oncogene. 2020 Mar 10. pii: 10.1038/s41388-020-1249.
    PubMed     Abstract available


    February 2020
  6. ZHANG G, Tang X, Liang L, Zhang W, et al
    DNA and RNA sequencing identified a novel oncogene VPS35 in liver hepatocellular carcinoma.
    Oncogene. 2020 Feb 19. pii: 10.1038/s41388-020-1215.
    PubMed     Abstract available


  7. LUIKEN S, Fraas A, Bieg M, Sugiyanto R, et al
    NOTCH target gene HES5 mediates oncogenic and tumor suppressive functions in hepatocarcinogenesis.
    Oncogene. 2020 Feb 13. pii: 10.1038/s41388-020-1198.
    PubMed     Abstract available


  8. CHEN P, Duan X, Li X, Li J, et al
    HIPK2 suppresses tumor growth and progression of hepatocellular carcinoma through promoting the degradation of HIF-1alpha.
    Oncogene. 2020 Feb 7. pii: 10.1038/s41388-020-1190.
    PubMed     Abstract available


  9. GUAN C, He L, Chang Z, Gu X, et al
    Correction: ZNF774 is a potent suppressor of hepatocarcinogenesis through dampening the NOTCH2 signaling.
    Oncogene. 2020 Feb 3. pii: 10.1038/s41388-020-1180.
    PubMed     Abstract available


    January 2020
  10. GU L, Zhu Y, Lin X, Tan X, et al
    Stabilization of FASN by ACAT1-mediated GNPAT acetylation promotes lipid metabolism and hepatocarcinogenesis.
    Oncogene. 2020 Jan 23. pii: 10.1038/s41388-020-1156.
    PubMed     Abstract available


  11. GUAN YF, Huang QL, Ai YL, Chen QT, et al
    Nur77-activated lncRNA WFDC21P attenuates hepatocarcinogenesis via modulating glycolysis.
    Oncogene. 2020 Jan 20. pii: 10.1038/s41388-020-1158.
    PubMed     Abstract available


    December 2019
  12. ZHOU Q, Huang T, Jiang Z, Ge C, et al
    Upregulation of SNX5 predicts poor prognosis and promotes hepatocellular carcinoma progression by modulating the EGFR-ERK1/2 signaling pathway.
    Oncogene. 2019 Dec 9. pii: 10.1038/s41388-019-1131.
    PubMed     Abstract available


    November 2019
  13. ZHONG R, Tian J, Fu M, Ma S, et al
    LINC01149 variant modulates MICA expression that facilitates hepatitis B virus spontaneous recovery but increases hepatocellular carcinoma risk.
    Oncogene. 2019 Nov 21. pii: 10.1038/s41388-019-1117.
    PubMed     Abstract available


  14. DONG KS, Chen Y, Yang G, Liao ZB, et al
    TGF-beta1 accelerates the hepatitis B virus X-induced malignant transformation of hepatic progenitor cells by upregulating miR-199a-3p.
    Oncogene. 2019 Nov 18. pii: 10.1038/s41388-019-1107.
    PubMed     Abstract available


  15. THOMSEN MK, Skouboe MK, Boularan C, Vernejoul F, et al
    The cGAS-STING pathway is a therapeutic target in a preclinical model of hepatocellular carcinoma.
    Oncogene. 2019 Nov 18. pii: 10.1038/s41388-019-1108.
    PubMed     Abstract available


  16. ZHAO J, Hou Y, Yin C, Hu J, et al
    Upregulation of histamine receptor H1 promotes tumor progression and contributes to poor prognosis in hepatocellular carcinoma.
    Oncogene. 2019 Nov 18. pii: 10.1038/s41388-019-1093.
    PubMed     Abstract available


  17. ELIAS D, Vever H, Laenkholm AV, Gjerstorff MF, et al
    Correction: VersicanV1 promotes proliferation and metastasis of hepatocellular carcinoma through the activation of EGFR-PI3K-AKT pathway.
    Oncogene. 2019 Nov 11. pii: 10.1038/s41388-019-1096.
    PubMed     Abstract available


  18. ZHANGYUAN G, Wang F, Zhang H, Jiang R, et al
    Correction: VersicanV1 promotes proliferation and metastasis of hepatocellular carcinoma through the activation of EGFR-PI3K-AKT pathway.
    Oncogene. 2019 Nov 7. pii: 10.1038/s41388-019-1095.
    PubMed     Abstract available


    October 2019
  19. XU G, Feng D, Yao Y, Li P, et al
    Listeria-based hepatocellular carcinoma vaccine facilitates anti-PD-1 therapy by regulating macrophage polarization.
    Oncogene. 2019 Oct 28. pii: 10.1038/s41388-019-1072.
    PubMed     Abstract available


  20. GUAN C, He L, Chang Z, Gu X, et al
    ZNF774 is a potent suppressor of hepatocarcinogenesis through dampening the NOTCH2 signaling.
    Oncogene. 2019 Oct 28. pii: 10.1038/s41388-019-1075.
    PubMed     Abstract available


  21. ZHANGYUAN G, Wang F, Zhang H, Jiang R, et al
    VersicanV1 promotes proliferation and metastasis of hepatocellular carcinoma through the activation of EGFR-PI3K-AKT pathway.
    Oncogene. 2019 Oct 11. pii: 10.1038/s41388-019-1052.
    PubMed     Abstract available


  22. LI B, Chen Y, Wang F, Guo J, et al
    Bmi1 drives hepatocarcinogenesis by repressing the TGFbeta2/SMAD signalling axis.
    Oncogene. 2019 Oct 7. pii: 10.1038/s41388-019-1043.
    PubMed     Abstract available


    September 2019
  23. LI X, Ding J, Wang X, Cheng Z, et al
    NUDT21 regulates circRNA cyclization and ceRNA crosstalk in hepatocellular carcinoma.
    Oncogene. 2019 Sep 30. pii: 10.1038/s41388-019-1030.
    PubMed     Abstract available


  24. HSU YL, Huang MS, Hung JY, Chang WA, et al
    Bone-marrow-derived cell-released extracellular vesicle miR-92a regulates hepatic pre-metastatic niche in lung cancer.
    Oncogene. 2019 Sep 26. pii: 10.1038/s41388-019-1024.
    PubMed     Abstract available


    August 2019
  25. YUAN YM, Ma N, Zhang EB, Chen TW, et al
    BMP10 suppresses hepatocellular carcinoma progression via PTPRS-STAT3 axis.
    Oncogene. 2019 Aug 15. pii: 10.1038/s41388-019-0943.
    PubMed     Abstract available


  26. SHANKARAIAH RC, Callegari E, Guerriero P, Rimessi A, et al
    Metformin prevents liver tumourigenesis by attenuating fibrosis in a transgenic mouse model of hepatocellular carcinoma.
    Oncogene. 2019 Aug 13. pii: 10.1038/s41388-019-0942.
    PubMed     Abstract available


  27. WANG J, Li N, Huang ZB, Fu S, et al
    HBx regulates transcription factor PAX8 stabilization to promote the progression of hepatocellular carcinoma.
    Oncogene. 2019 Aug 7. pii: 10.1038/s41388-019-0907.
    PubMed     Abstract available


    July 2019
  28. CHU TH, Huang ST, Yang SF, Li CJ, et al
    Hepatoma-derived growth factor participates in Helicobacter Pylori-induced neutrophils recruitment, gastritis and gastric carcinogenesis.
    Oncogene. 2019 Jul 22. pii: 10.1038/s41388-019-0886.
    PubMed     Abstract available


  29. WEI T, Weiler SME, Toth M, Sticht C, et al
    YAP-dependent induction of UHMK1 supports nuclear enrichment of the oncogene MYBL2 and proliferation in liver cancer cells.
    Oncogene. 2019;38:5541-5550.
    PubMed     Abstract available


    June 2019
  30. BAO D, Zhao J, Zhou X, Yang Q, et al
    Mitochondrial fission-induced mtDNA stress promotes tumor-associated macrophage infiltration and HCC progression.
    Oncogene. 2019;38:5007-5020.
    PubMed     Abstract available


    May 2019
  31. MARCHAND B, Pitarresi JR, Reichert M, Suzuki K, et al
    PRRX1 isoforms cooperate with FOXM1 to regulate the DNA damage response in pancreatic cancer cells.
    Oncogene. 2019;38:4325-4339.
    PubMed     Abstract available


    April 2019
  32. CUI Y, Wu X, Lin C, Zhang X, et al
    AKIP1 promotes early recurrence of hepatocellular carcinoma through activating the Wnt/beta-catenin/CBP signaling pathway.
    Oncogene. 2019 Apr 1. pii: 10.1038/s41388-019-0807.
    PubMed     Abstract available


    March 2019
  33. YANG H, Zhu R, Zhao X, Liu L, et al
    Sirtuin-mediated deacetylation of hnRNP A1 suppresses glycolysis and growth in hepatocellular carcinoma.
    Oncogene. 2019 Mar 11. pii: 10.1038/s41388-019-0764.
    PubMed     Abstract available


  34. WANG Y, Xie BH, Lin WH, Huang YH, et al
    Amplification of SMYD3 promotes tumorigenicity and intrahepatic metastasis of hepatocellular carcinoma via upregulation of CDK2 and MMP2.
    Oncogene. 2019 Mar 6. pii: 10.1038/s41388-019-0766.
    PubMed     Abstract available


    February 2019
  35. DANG S, Zhou J, Chen Y, Chen P, et al
    Dynamic expression of ZNF382 and its tumor-suppressor role in hepatitis B virus-related hepatocellular carcinogenesis.
    Oncogene. 2019 Feb 25. pii: 10.1038/s41388-019-0759.
    PubMed     Abstract available


  36. TORRES-HERNANDEZ A, Wang W, Nikiforov Y, Tejada K, et al
    Targeting SYK signaling in myeloid cells protects against liver fibrosis and hepatocarcinogenesis.
    Oncogene. 2019 Feb 11. pii: 10.1038/s41388-019-0734.
    PubMed     Abstract available


    January 2019
  37. FANG S, Liu M, Li L, Zhang FF, et al
    Lymphoid enhancer-binding factor-1 promotes stemness and poor differentiation of hepatocellular carcinoma by directly activating the NOTCH pathway.
    Oncogene. 2019 Jan 29. pii: 10.1038/s41388-019-0704.
    PubMed     Abstract available


  38. HUANG JF, Jiang HY, Cai H, Liu Y, et al
    Genome-wide screening identifies oncofetal lncRNA Ptn-dt promoting the proliferation of hepatocellular carcinoma cells by regulating the Ptn receptor.
    Oncogene. 2019 Jan 14. pii: 10.1038/s41388-018-0643.
    PubMed     Abstract available


  39. ZHAO X, Reebye V, Hitchen P, Fan J, et al
    Mechanisms involved in the activation of C/EBPalpha by small activating RNA in hepatocellular carcinoma.
    Oncogene. 2019 Jan 14. pii: 10.1038/s41388-018-0665.
    PubMed     Abstract available


  40. GUHA P, Gardell J, Darpolor J, Cunetta M, et al
    STAT3 inhibition induces Bax-dependent apoptosis in liver tumor myeloid-derived suppressor cells.
    Oncogene. 2019;38:533-548.
    PubMed     Abstract available


  41. WANG LT, Wang SN, Chiou SS, Liu KY, et al
    TIP60-dependent acetylation of the SPZ1-TWIST complex promotes epithelial-mesenchymal transition and metastasis in liver cancer.
    Oncogene. 2019;38:518-532.
    PubMed     Abstract available


    December 2018
  42. CORTES E, Lachowski D, Rice A, Thorpe SD, et al
    Tamoxifen mechanically deactivates hepatic stellate cells via the G protein-coupled estrogen receptor.
    Oncogene. 2018 Dec 21. pii: 10.1038/s41388-018-0631.
    PubMed     Abstract available


  43. LAOUIREM S, Sannier A, Norkowski E, Cauchy F, et al
    Endothelial fatty liver binding protein 4: a new targetable mediator in hepatocellular carcinoma related to metabolic syndrome.
    Oncogene. 2018 Dec 21. pii: 10.1038/s41388-018-0597.
    PubMed     Abstract available


  44. ZHANG H, Deng T, Ge S, Liu Y, et al
    Exosome circRNA secreted from adipocytes promotes the growth of hepatocellular carcinoma by targeting deubiquitination-related USP7.
    Oncogene. 2018 Dec 13. pii: 10.1038/s41388-018-0619.
    PubMed     Abstract available


  45. AHODANTIN J, Bou-Nader M, Cordier C, Megret J, et al
    Hepatitis B virus X protein promotes DNA damage propagation through disruption of liver polyploidization and enhances hepatocellular carcinoma initiation.
    Oncogene. 2018 Dec 11. pii: 10.1038/s41388-018-0607.
    PubMed     Abstract available


    November 2018
  46. CHONG YC, Lim TE, Fu Y, Shin EM, et al
    Indian Hedgehog links obesity to development of hepatocellular carcinoma.
    Oncogene. 2018 Nov 23. pii: 10.1038/s41388-018-0585.
    PubMed     Abstract available


    October 2018
  47. WEN Y, Zhou X, Lu M, He M, et al
    Bclaf1 promotes angiogenesis by regulating HIF-1alpha transcription in hepatocellular carcinoma.
    Oncogene. 2018 Oct 26. pii: 10.1038/s41388-018-0552.
    PubMed     Abstract available


  48. DI LEO L, Vegliante R, Ciccarone F, Salvatori I, et al
    Forcing ATGL expression in hepatocarcinoma cells imposes glycolytic rewiring through PPAR-alpha/p300-mediated acetylation of p53.
    Oncogene. 2018 Oct 26. pii: 10.1038/s41388-018-0545.
    PubMed     Abstract available


    September 2018
  49. DOU C, Zhou Z, Xu Q, Liu Z, et al
    Hypoxia-induced TUFT1 promotes the growth and metastasis of hepatocellular carcinoma by activating the Ca(2+)/PI3K/AKT pathway.
    Oncogene. 2018 Sep 24. pii: 10.1038/s41388-018-0505.
    PubMed     Abstract available


    August 2018
  50. HAN J, Wang F, Lan Y, Wang J, et al
    KIFC1 regulated by miR-532-3p promotes epithelial-to-mesenchymal transition and metastasis of hepatocellular carcinoma via gankyrin/AKT signaling.
    Oncogene. 2018 Aug 16. pii: 10.1038/s41388-018-0440.
    PubMed     Abstract available


  51. LAI CY, Liu H, Tin KX, Huang Y, et al
    Identification of UAP1L1 as a critical factor for protein O-GlcNAcylation and cell proliferation in human hepatoma cells.
    Oncogene. 2018 Aug 10. pii: 10.1038/s41388-018-0442.
    PubMed     Abstract available


  52. TOSHIYAMA R, Konno M, Eguchi H, Takemoto H, et al
    Poly(ethylene glycol)-poly(lysine) block copolymer-ubenimex conjugate targets aminopeptidase N and exerts an antitumor effect in hepatocellular carcinoma stem cells.
    Oncogene. 2018 Aug 8. pii: 10.1038/s41388-018-0406.
    PubMed     Abstract available


  53. MENG J, Chen S, Lei YY, Han JX, et al
    Hsp90beta promotes aggressive vasculogenic mimicry via epithelial-mesenchymal transition in hepatocellular carcinoma.
    Oncogene. 2018 Aug 7. pii: 10.1038/s41388-018-0428.
    PubMed     Abstract available


  54. YANG X, Qu S, Wang L, Zhang H, et al
    PTBP3 splicing factor promotes hepatocellular carcinoma by destroying the splicing balance of NEAT1 and pre-miR-612.
    Oncogene. 2018 Aug 1. pii: 10.1038/s41388-018-0416.
    PubMed     Abstract available


  55. YOON S, Lee EJ, Choi JH, Chung T, et al
    Recapitulation of pharmacogenomic data reveals that invalidation of SULF2 enhance sorafenib susceptibility in liver cancer.
    Oncogene. 2018;37:4443-4454.
    PubMed     Abstract available


    July 2018
  56. YANG Y, Wu XQ, Li WX, Huang HM, et al
    PSTPIP2 connects DNA methylation to macrophage polarization in CCL4-induced mouse model of hepatic fibrosis.
    Oncogene. 2018 Jul 11. pii: 10.1038/s41388-018-0383.
    PubMed     Abstract available


  57. VANIOTIS G, Rayes RF, Qi S, Milette S, et al
    Collagen IV-conveyed signals can regulate chemokine production and promote liver metastasis.
    Oncogene. 2018;37:3790-3805.
    PubMed     Abstract available


    June 2018
  58. KANDA M, Tanaka H, Shimizu D, Miwa T, et al
    SYT7 acts as a driver of hepatic metastasis formation of gastric cancer cells.
    Oncogene. 2018 Jun 1. pii: 10.1038/s41388-018-0335.
    PubMed     Abstract available


  59. REEBYE V, Huang KW, Lin V, Jarvis S, et al
    Gene activation of CEBPA using saRNA: preclinical studies of the first in human saRNA drug candidate for liver cancer.
    Oncogene. 2018;37:3216-3228.
    PubMed     Abstract available


  60. CHEN Z, Gao Y, Yao L, Liu Y, et al
    LncFZD6 initiates Wnt/beta-catenin and liver TIC self-renewal through BRG1-mediated FZD6 transcriptional activation.
    Oncogene. 2018;37:3098-3112.
    PubMed     Abstract available


    May 2018
  61. LIU H, Chen W, Zhi X, Chen EJ, et al
    Tumor-derived exosomes promote tumor self-seeding in hepatocellular carcinoma by transferring miRNA-25-5p to enhance cell motility.
    Oncogene. 2018 May 22. pii: 10.1038/s41388-018-0309.
    PubMed     Abstract available


  62. TAN S, Li H, Zhang W, Shao Y, et al
    NUDT21 negatively regulates PSMB2 and CXXC5 by alternative polyadenylation and contributes to hepatocellular carcinoma suppression.
    Oncogene. 2018 May 21. pii: 10.1038/s41388-018-0280.
    PubMed     Abstract available


  63. PINATO DJ
    Circulating-free tumour DNA and the promise of disease phenotyping in hepatocellular carcinoma.
    Oncogene. 2018 May 14. pii: 10.1038/s41388-018-0262.
    PubMed    


  64. ZHAO Y, Hu X, Wei L, Song D, et al
    PARP10 suppresses tumor metastasis through regulation of Aurora A activity.
    Oncogene. 2018;37:2921-2935.
    PubMed     Abstract available


  65. JIANG Y, Xu E, Zhang J, Chen M, et al
    The Rbm38-p63 feedback loop is critical for tumor suppression and longevity.
    Oncogene. 2018;37:2863-2872.
    PubMed     Abstract available


  66. ZHANG H, Song Y, Yang H, Liu Z, et al
    Tumor cell-intrinsic Tim-3 promotes liver cancer via NF-kappaB/IL-6/STAT3 axis.
    Oncogene. 2018;37:2456-2468.
    PubMed     Abstract available


    April 2018
  67. LABGAA I, Villacorta-Martin C, D'Avola D, Craig AJ, et al
    A pilot study of ultra-deep targeted sequencing of plasma DNA identifies driver mutations in hepatocellular carcinoma.
    Oncogene. 2018 Apr 9. pii: 10.1038/s41388-018-0206.
    PubMed     Abstract available


    March 2018
  68. SU T, Liao J, Dai Z, Xu L, et al
    Stress-induced phosphoprotein 1 mediates hepatocellular carcinoma metastasis after insufficient radiofrequency ablation.
    Oncogene. 2018 Mar 21. pii: 10.1038/s41388-018-0169.
    PubMed     Abstract available


  69. CHU PC, Lin PC, Wu HY, Lin KT, et al
    Mutant KRAS promotes liver metastasis of colorectal cancer, in part, by upregulating the MEK-Sp1-DNMT1-miR-137-YB-1-IGF-IR signaling pathway.
    Oncogene. 2018 Mar 21. pii: 10.1038/s41388-018-0222.
    PubMed     Abstract available


  70. LIU X, Bi L, Wang Q, Wen M, et al
    miR-1204 targets VDR to promotes epithelial-mesenchymal transition and metastasis in breast cancer.
    Oncogene. 2018 Mar 20. pii: 10.1038/s41388-018-0215.
    PubMed     Abstract available


  71. EHEDEGO H, Mohs A, Jansen B, Hiththetiya K, et al
    Loss of Cyclin E1 attenuates hepatitis and hepatocarcinogenesis in a mouse model of chronic liver injury.
    Oncogene. 2018 Mar 19. pii: 10.1038/s41388-018-0181.
    PubMed     Abstract available


  72. WANG J, Dong M, Xu Z, Song X, et al
    Notch2 controls hepatocyte-derived cholangiocarcinoma formation in mice.
    Oncogene. 2018 Mar 16. pii: 10.1038/s41388-018-0188.
    PubMed     Abstract available


  73. DONG L, Yu L, Bai C, Liu L, et al
    USP27-mediated Cyclin E stabilization drives cell cycle progression and hepatocellular tumorigenesis.
    Oncogene. 2018 Mar 2. pii: 10.1038/s41388-018-0137.
    PubMed     Abstract available


  74. IM JY, Kim BK, Lee JY, Park SH, et al
    DDIAS suppresses TRAIL-mediated apoptosis by inhibiting DISC formation and destabilizing caspase-8 in cancer cells.
    Oncogene. 2018;37:1251-1262.
    PubMed     Abstract available


  75. YANG JB, Zhao ZB, Liu QZ, Hu TD, et al
    FoxO1 is a regulator of MHC-II expression and anti-tumor effect of tumor-associated macrophages.
    Oncogene. 2018;37:1192-1204.
    PubMed     Abstract available


    February 2018
  76. MA D, Chen X, Zhang PY, Zhang H, et al
    Upregulation of the ALDOA/DNA-PK/p53 pathway by dietary restriction suppresses tumor growth.
    Oncogene. 2018;37:1041-1048.
    PubMed     Abstract available


  77. DI RUOCCO F, Basso V, Rivoire M, Mehlen P, et al
    Alu RNA accumulation induces epithelial-to-mesenchymal transition by modulating miR-566 and is associated with cancer progression.
    Oncogene. 2018;37:627-637.
    PubMed     Abstract available


    January 2018
  78. HUA S, Lei L, Deng L, Weng X, et al
    miR-139-5p inhibits aerobic glycolysis, cell proliferation, migration, and invasion in hepatocellular carcinoma via a reciprocal regulatory interaction with ETS1.
    Oncogene. 2018 Jan 16. pii: 10.1038/s41388-017-0057.
    PubMed     Abstract available


  79. LIU MX, Jin L, Sun SJ, Liu P, et al
    Metabolic reprogramming by PCK1 promotes TCA cataplerosis, oxidative stress and apoptosis in liver cancer cells and suppresses hepatocellular carcinoma.
    Oncogene. 2018 Jan 16. pii: 10.1038/s41388-017-0070.
    PubMed     Abstract available


  80. MARTINEZ-ORDONEZ A, Seoane S, Cabezas P, Eiro N, et al
    Breast cancer metastasis to liver and lung is facilitated by Pit-1-CXCL12-CXCR4 axis.
    Oncogene. 2018 Jan 11. pii: 10.1038/s41388-017-0036.
    PubMed     Abstract available


    December 2017
  81. GUO P, Wang Y, Dai C, Tao C, et al
    Ribosomal protein S15a promotes tumor angiogenesis via enhancing Wnt/beta-catenin-induced FGF18 expression in hepatocellular carcinoma.
    Oncogene. 2017 Dec 15. pii: 10.1038/s41388-017-0017.
    PubMed     Abstract available


  82. BLOMME A, Van Simaeys G, Doumont G, Costanza B, et al
    Murine stroma adopts a human-like metabolic phenotype in the PDX model of colorectal cancer and liver metastases.
    Oncogene. 2017 Dec 15. pii: 10.1038/s41388-017-0018.
    PubMed     Abstract available


    November 2017
  83. DING D, Huang H, Jiang W, Yu W, et al
    Reticulocalbin-2 enhances hepatocellular carcinoma proliferation via modulating the EGFR-ERK pathway.
    Oncogene. 2017;36:6747-6748.
    PubMed     Abstract available


  84. NAKATSUKA T, Tateishi K, Kudo Y, Yamamoto K, et al
    Impact of histone demethylase KDM3A-dependent AP-1 transactivity on hepatotumorigenesis induced by PI3K activation.
    Oncogene. 2017;36:6262-6271.
    PubMed     Abstract available


    October 2017
  85. DEBEBE A, Medina V, Chen CY, Mahajan IM, et al
    Wnt/beta-catenin activation and macrophage induction during liver cancer development following steatosis.
    Oncogene. 2017;36:6020-6029.
    PubMed     Abstract available


  86. REN T, Zhang H, Wang J, Zhu J, et al
    MCU-dependent mitochondrial Ca2+ inhibits NAD+/SIRT3/SOD2 pathway to promote ROS production and metastasis of HCC cells.
    Oncogene. 2017;36:5897-5909.
    PubMed     Abstract available


  87. NAKAYAMA M, Sakai E, Echizen K, Yamada Y, et al
    Intestinal cancer progression by mutant p53 through the acquisition of invasiveness associated with complex glandular formation.
    Oncogene. 2017;36:5885-5896.
    PubMed     Abstract available


  88. GUO P, Ma X, Zhao W, Huai W, et al
    TRIM31 is upregulated in hepatocellular carcinoma and promotes disease progression by inducing ubiquitination of TSC1-TSC2 complex.
    Oncogene. 2017 Oct 2. doi: 10.1038/onc.2017.
    PubMed     Abstract available


    September 2017
  89. XIE X, Guo P, Yu H, Wang Y, et al
    Ribosomal proteins: insight into molecular roles and functions in hepatocellular carcinoma.
    Oncogene. 2017 Sep 25. doi: 10.1038/onc.2017.
    PubMed     Abstract available


  90. TRAN DDH, Kessler C, Niehus SE, Mahnkopf M, et al
    Myc target gene, long intergenic noncoding RNA, Linc00176 in hepatocellular carcinoma regulates cell cycle and cell survival by titrating tumor suppressor microRNAs.
    Oncogene. 2017 Sep 4. doi: 10.1038/onc.2017.
    PubMed     Abstract available


    August 2017
  91. FENG GX, Li J, Yang Z, Zhang SQ, et al
    Hepatitis B virus X protein promotes the development of liver fibrosis and hepatoma through downregulation of miR-30e targeting P4HA2 mRNA.
    Oncogene. 2017 Aug 28. doi: 10.1038/onc.2017.
    PubMed     Abstract available


  92. LI J, Huang Q, Long X, Guo X, et al
    Mitochondrial elongation-mediated glucose metabolism reprogramming is essential for tumour cell survival during energy stress.
    Oncogene. 2017;36:4901-4912.
    PubMed     Abstract available


  93. HAN H, Yang B, Wang W
    Angiomotin-like 2 interacts with and negatively regulates AKT.
    Oncogene. 2017;36:4662-4669.
    PubMed     Abstract available


  94. LI J, Hu SB, Wang LY, Zhang X, et al
    Autophagy-dependent generation of Axin2+ cancer stem-like cells promotes hepatocarcinogenesis in liver cirrhosis.
    Oncogene. 2017 Aug 7. doi: 10.1038/onc.2017.
    PubMed     Abstract available


  95. GOVAERE O, Petz M, Wouters J, Vandewynckel YP, et al
    The PDGFRalpha-laminin B1-keratin 19 cascade drives tumor progression at the invasive front of human hepatocellular carcinoma.
    Oncogene. 2017 Aug 7. doi: 10.1038/onc.2017.
    PubMed     Abstract available


  96. WANG LT, Chiou SS, Chai CY, Hsi E, et al
    Transcription factor SPZ1 promotes TWIST-mediated epithelial-mesenchymal transition and oncogenesis in human liver cancer.
    Oncogene. 2017;36:4405-4414.
    PubMed     Abstract available


    July 2017
  97. DING D, Huang H, Jiang W, Yu W, et al
    Reticulocalbin-2 enhances hepatocellular carcinoma proliferation via modulating the EGFR-ERK pathway.
    Oncogene. 2017 Jul 24. doi: 10.1038/onc.2017.
    PubMed     Abstract available


  98. FAN LC, Shiau CW, Tai WT, Hung MH, et al
    SHP-1 is a negative regulator of epithelial-mesenchymal transition in hepatocellular carcinoma.
    Oncogene. 2017 Jul 17. doi: 10.1038/onc.2017.
    PubMed     Abstract available


    June 2017
  99. XIONG H, Ni Z, He J, Jiang S, et al
    LncRNA HULC triggers autophagy via stabilizing Sirt1 and attenuates the chemosensitivity of HCC cells.
    Oncogene. 2017;36:3528-3540.
    PubMed     Abstract available


    May 2017
  100. CROSAS-MOLIST E, Bertran E, Rodriguez-Hernandez I, Herraiz C, et al
    The NADPH oxidase NOX4 represses epithelial to amoeboid transition and efficient tumour dissemination.
    Oncogene. 2017;36:3002-3014.
    PubMed     Abstract available


  101. CHI HC, Chen SL, Lin SL, Tsai CY, et al
    Thyroid hormone protects hepatocytes from HBx-induced carcinogenesis by enhancing mitochondrial turnover.
    Oncogene. 2017 May 15. doi: 10.1038/onc.2017.
    PubMed     Abstract available


  102. XIN B, Yamamoto M, Fujii K, Ooshio T, et al
    Critical role of Myc activation in mouse hepatocarcinogenesis induced by the activation of AKT and RAS pathways.
    Oncogene. 2017 May 8. doi: 10.1038/onc.2017.
    PubMed     Abstract available


    March 2017
  103. CHEN H, Cai W, Chu ES, Tang J, et al
    Hepatic cyclooxygenase-2 overexpression induced spontaneous hepatocellular carcinoma formation in mice.
    Oncogene. 2017 Mar 27. doi: 10.1038/onc.2017.
    PubMed     Abstract available


  104. HU X, Zhao Y, Wei L, Zhu B, et al
    CCDC178 promotes hepatocellular carcinoma metastasis through modulation of anoikis.
    Oncogene. 2017 Mar 20. doi: 10.1038/onc.2017.
    PubMed     Abstract available


  105. ZHOU M, Mok MT, Sun H, Chan AW, et al
    The anti-diabetic drug exenatide, a glucagon-like peptide-1 receptor agonist, counteracts hepatocarcinogenesis through cAMP-PKA-EGFR-STAT3 axis.
    Oncogene. 2017 Mar 20. doi: 10.1038/onc.2017.
    PubMed     Abstract available


    February 2017
  106. BATTISTELLI C, Cicchini C, Santangelo L, Tramontano A, et al
    The Snail repressor recruits EZH2 to specific genomic sites through the enrollment of the lncRNA HOTAIR in epithelial-to-mesenchymal transition.
    Oncogene. 2017;36:942-955.
    PubMed     Abstract available


    September 2016
  107. HAASE G, Gavert N, Brabletz T, Ben-Ze'ev A, et al
    A point mutation in the extracellular domain of L1 blocks its capacity to confer metastasis in colon cancer cells via CD10.
    Oncogene. 2016 Sep 19. doi: 10.1038/onc.2016.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Liver Diseases is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: